Pharmaust Phase II K9 Trial, page-41

A few random reasons that Elanco will be all over this trial like a fat kid on a cupcake:

...Elanco helped devise the trial.
...Elanco provided the drug.
...Elanco have the option of taking over the development of the compound upon favourable Ph2 results.
...Elanco knows it works.
...Elanco knows its safe.
...Elanco knows firsthand that it’s been used in the food chain for millions and millions of doses with no ill-effects on humans or animals.
...Elanco knows it reduces tumour mass as per the previous trial a few years back.
...Elanco knows the drug has active metabolites.
...Elanco knows the drug is now palatable.
...Elanco sees the untapped market that this drug can fill.

Elanco stands to benefit very handsomely from this drug if/when it’s proven. They would be unworthy of their status as a market leader if they didn’t have someone on-the-ground overseeing the trial and reporting back to HQ.

And mate, it’s a lot more than a dog going for a walk or chewing a shoe... a helluva lot more.